Intranasal Bioavailability of Insulin Powder Formulations: Effect of Permeation Enhancer-to-Protein Ratio
- 1 August 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 80 (8) , 725-729
- https://doi.org/10.1002/jps.2600800803
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Effect of Sodium Tauro-24,25-Dihydrofusidate on the Nasal Absorption of Human Growth Hormone in Three Animal ModelsPharmaceutical Research, 1990
- Influence of molecular weight and charge on nasal absorption of dextran and DEAE-dextran in rabbitsInternational Journal of Pharmaceutics, 1989
- Degradable starch microspheres as a nasal delivery system for insulinInternational Journal of Pharmaceutics, 1988
- Bioadhesive microspheres as a potential nasal drug delivery systemInternational Journal of Pharmaceutics, 1987
- Analysis of Structural Requirements for the Absorption of Drugs and Macromolecules from the Nasal CavityJournal of Pharmaceutical Sciences, 1987
- Effects of Sodium Taurodihydrofusidate on Nasal Absorption of Insulin in SheepJournal of Pharmaceutical Sciences, 1987
- Powder dosage form of insulin for nasal administrationJournal of Controlled Release, 1984
- Nasal Absorption of Insulin in DogsDiabetes, 1978
- Solution properties of taurine and glycine conjugates of fusidic acid and its derivativesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- SIGNIFICANCE OF THE pH OF NASAL SECRETIONS IN SITUJAMA Otolaryngology–Head & Neck Surgery, 1941